Clinical Trial Update: Phase Ib/II Study to Evaluate the Efficacy and Safety of GH509 Versus Placebo in Patients With NASH/NAFLD [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/II trial evaluating GH509 versus placebo for NASH/NAFLD is ongoing; no results yet from the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• GH509

Snippet

Sponsor: 1Globe Biomedical Co., Ltd. | Conditions: NASH, NAFLD | Phase 1, Phase 2 | Status: UNKNOWN